Study Comparing Sirolimus/Prograf vs Sirolimus/CsA in High-Risk Renal Transplant Recipients

NCT00470665 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

460

Enrollment

INDUSTRY

Sponsor class

Conditions

Renal Allograft Recipients

Interventions

DRUG: Rapamune

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer